Kisspeptin can induce ovulation by initiating GnRH release, and synthetic kisspeptin is being tried to timely trigger ovulation with less ovarian hyperstimulation risk
In everyday practice, this most often means somewhere between 0.5 mg and 2.0 mg per week, though there is no consensus clinical definition and no randomized controlled trial has tested a true microdose as a primary endpoint (Cedars-Sinai, Hackensack Meridian Health, STAT News)
Results The meta-analysis included 10 randomized controlled trials with 42,651 participants, of which 2,820 were on combination therapy and the rest on SGLT-2i (37.1%), GLP-1RA (20.1%) monotherapies or TAU (42.8%)
[1] Vitamin B 12 deficiency, which is reversible, is occasionally confused with acute myeloid leukemia, which is an irreversible condition presenting with some of the same hematological symptoms, including hypercellular bone marrow with blastic differentiation and hypersegmented neutrophils